Drug Discovery &
Clinical Development
Target ID, molecular design, trial optimisation, digital biomarkers, safety and efficacy prediction.
The twenty-five people moving pharma from algorithm to outcome — surfaced once a year, defended by independent judges, named to the industry's only canon for applied AI.
Molecules are being designed by models. Trials are being run on synthetic cohorts. HCP engagement is being rewritten in real time. Market access is being forecast before the first payer conversation. None of this is coming — it's here, in production, at scale.
And yet the people driving it remain largely invisible. Their work lives inside decks, inside firewalls, inside the one brand team that shipped it. The industry has no shared list of who's actually doing this — no benchmark, no canon, no annual moment.
AI Health 25 is that moment. One list. Twenty-five names. Published once a year. Defended by independent judges and the industry's sharpest media voice.
VisionThe definitive annual list of people moving AI forward in pharma and life sciences — the one recognition the industry agrees matters. |
MissionSurface the 25 leaders whose AI work is creating measurable change across manufacturers, agencies, biotech and medtech — and tell their stories in a way that raises the bar for everyone else. |
PrincipleWe're not awarding AI. We're naming the people who are using it to change how medicine gets made, marketed, and delivered. |
Target ID, molecular design, trial optimisation, digital biomarkers, safety and efficacy prediction.
Brand strategy, forecasting, segmentation, and decision intelligence.
Personalised HCP journeys, content intelligence, next-best-action, scientific communications.
Rep insights, call planning, next-best-interaction, medical–commercial orchestration, frontline intelligence.
Access modelling, HEOR automation, reimbursement prediction, payer negotiation.
Patient engagement, adherence, navigation, diagnostic support, remote monitoring.
Nominations open publicly. Peers, managers, PR teams and self-nominations all welcome. A structured form captures nominee profile, initiative, outcomes, scale, and responsible-AI practice.
Doceree's editorial team screens every submission for eligibility, evidence quality, and conflict transparency before anything reaches the panel.
A panel of 8 senior, independent judges — drawn from pharma, academia, consulting, medtech, regulatory, venture, and scientific publishing — scores shortlisted nominations against a five-pillar rubric.
Judges convene to debate top-scoring candidates and ensure balance across categories, geographies and functions. The final 25 are formalised by Doceree's editorial leadership.
Every nomination is scored against the same five-pillar rubric. The rubric is public. Claims must be backed by outcomes, publications, or deployed case studies.
Quantified business or patient outcomes — speed-to-market, efficiency, HCP engagement lift, trial acceleration, access improvement.
Originality and technical sophistication. Distinguishes genuine invention from off-the-shelf adoption.
Breadth of deployment across brands, markets, and functions — plus the potential to scale further.
The individual's role in advancing the agenda internally and across the ecosystem: thought leadership, standards, mentorship.
Commitment to ethics in practice: privacy, transparency, bias mitigation, regulatory rigour.
8 senior judges. None from competing vendors. None scoring their own network.
The rubric, the process, and the conflict protocols are public.
Nominations are free. Sponsorship does not influence selection.
Doceree's editorial team operates separately from commercial. No client, partner, or sponsor influences the final list.
Claims must be backed by outcomes, publications, or deployed case studies.
The list reveal culminates in an invitation-only evening in New York — designed to feel like the industry's most exclusive dinner, not another ballroom event.
Invitation-only seated dinner
150 – 200 honourees, judges, nominators, partners and curated media
Keynote · 25 individual recognitions · 90-second honouree films · one on-stage fireside
AI-led matchmaking for post-dinner conversations
New York · September 2026
|
I / Recognition
The credit.
|
II / Access
The room.
|
| Jun — Jul 2026 | Nominations Open Now | Public call activated via Doceree channels. Nominations submitted free of charge. |
| Jul 2026 | Editorial Screening | Submissions screened for eligibility, evidence quality, and conflict transparency. |
| Aug 2026 | Panel Deliberations | Independent judges score shortlisted nominations against the five-pillar rubric. |
| Aug 2026 | Honourees Notified | Confidential notification. Editorial profiling and photography begins. |
| Sep 2026 | List Reveal & Gala | Invitation-only industry evening in New York. Publication goes live. |
Nominate a peer, a manager, a partner — or yourself. Nominations are free, take roughly ten minutes, and are reviewed by Doceree's editorial team before reaching the independent panel.
Strong nominations are specific. Tell us what the person built, what changed because of it, and what the evidence is.
Thank you. Our editorial team will review the submission within five business days. You'll hear from us if we need clarifying detail. Shortlist confirmations go out in late July.